1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF711 CTRPv2 pan-cancer AAC -0.098 0.02
mRNA MCHR2 CTRPv2 pan-cancer AAC -0.088 0.02
mRNA VPS37A CTRPv2 pan-cancer AAC -0.087 0.02
mRNA S100A10 CTRPv2 pan-cancer AAC 0.099 0.02
mRNA PHLDA2 CTRPv2 pan-cancer AAC 0.098 0.02
mRNA TJAP1 CTRPv2 pan-cancer AAC -0.089 0.02
mRNA SELM CTRPv2 pan-cancer AAC -0.094 0.02
mRNA ELP4 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA UBL3 CTRPv2 pan-cancer AAC 0.1 0.02
mRNA PREPL CTRPv2 pan-cancer AAC -0.09 0.02
Download CSV